Amylase-Trypsin-Inhibitoren (ATI) als Aktivatoren der angeborenen Immunantwort

Katharina Scherf* (First Author)

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)367-369
Number of pages3
JournalTagliche Praxis
Volume65
Issue number2
StatePublished - 2021
Externally publishedYes

Cite this